WO1994027589A3 - Antidepressant dosage form - Google Patents
Antidepressant dosage form Download PDFInfo
- Publication number
- WO1994027589A3 WO1994027589A3 PCT/US1994/006049 US9406049W WO9427589A3 WO 1994027589 A3 WO1994027589 A3 WO 1994027589A3 US 9406049 W US9406049 W US 9406049W WO 9427589 A3 WO9427589 A3 WO 9427589A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- antidepressant
- antidepressant dosage
- administering
- rate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70482/94A AU677080B2 (en) | 1993-05-27 | 1994-05-27 | Antidepressant dosage form |
EP94919286A EP0700289A1 (en) | 1993-05-27 | 1994-05-27 | Antidepressant dosage form |
JP7501005A JPH08510755A (en) | 1993-05-27 | 1994-05-27 | Antidepressant dosage form |
NO954694A NO954694L (en) | 1993-05-27 | 1995-11-21 | Dosage form for antidepressants |
FI955681A FI955681A0 (en) | 1993-05-27 | 1995-11-24 | Dosage form of antidepressant |
KR1019950705306A KR960702303A (en) | 1993-05-27 | 1995-11-27 | Anti-Inhibitor Formulation (Antidepressant Dosage Form) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US068,480 | 1993-05-27 | ||
US08/068,480 US6440457B1 (en) | 1993-05-27 | 1993-05-27 | Method of administering antidepressant dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994027589A2 WO1994027589A2 (en) | 1994-12-08 |
WO1994027589A3 true WO1994027589A3 (en) | 1995-01-26 |
Family
ID=22082852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/006049 WO1994027589A2 (en) | 1993-05-27 | 1994-05-27 | Antidepressant dosage form |
Country Status (11)
Country | Link |
---|---|
US (7) | US6440457B1 (en) |
EP (1) | EP0700289A1 (en) |
JP (4) | JPH08510755A (en) |
KR (1) | KR960702303A (en) |
AU (1) | AU677080B2 (en) |
CA (1) | CA2157186A1 (en) |
FI (1) | FI955681A0 (en) |
NO (1) | NO954694L (en) |
NZ (1) | NZ267841A (en) |
WO (1) | WO1994027589A2 (en) |
ZA (1) | ZA943743B (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
EP1738753B1 (en) * | 1993-06-28 | 2008-04-23 | Wyeth | New treatments using phenethylamine derivatives |
US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
EP1331003B1 (en) * | 1996-03-25 | 2015-08-26 | Wyeth LLC | Extended release formulation containing venlafaxine |
PE57198A1 (en) * | 1996-03-25 | 1998-10-10 | American Home Prod | PROLONGED RELEASE FORMULA |
GB9609094D0 (en) * | 1996-05-01 | 1996-07-03 | Univ Strathclyde | Delivery device |
US6517866B1 (en) | 1997-07-01 | 2003-02-11 | Pfizer Inc. | Sertraline salts and sustained-release dosage forms of sertraline |
UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
NZ506202A (en) | 1998-03-19 | 2003-10-31 | Bristol Myers Squibb Co | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
US6596776B2 (en) * | 1999-06-21 | 2003-07-22 | Hauser, Inc. | High molecular weight primary aliphatic alcohols obtained from natural products and uses thereof |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Extended release compositions comprising as active compound venlafaxine hydrochloride |
EP1451145A1 (en) | 2001-12-05 | 2004-09-01 | Wyeth | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
WO2003055475A1 (en) * | 2002-01-03 | 2003-07-10 | Lek Pharmaceutical And Chemical Company D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
AU2003229408A1 (en) * | 2002-06-10 | 2003-12-22 | Philippe Kriwin | Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor |
GB2392385A (en) * | 2002-09-02 | 2004-03-03 | Cipla Ltd | Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone |
AU2003278549A1 (en) * | 2002-11-28 | 2004-06-18 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
US8293799B2 (en) * | 2003-12-29 | 2012-10-23 | Osmotica Keresleedelmo és Szolgáltató KFT | Osmotic device containing a venlafaxine salt and a salt having an ion in common |
US20070077301A1 (en) * | 2002-12-23 | 2007-04-05 | Meyer Glenn A | Venlafaxine osmotic device formulation |
WO2004069228A2 (en) * | 2003-02-07 | 2004-08-19 | Omega Farma Ehf. | Sustained release formulations of venlafaxine |
JP2007521231A (en) * | 2003-08-08 | 2007-08-02 | バイオヴェイル ラボラトリーズ インコーポレイテッド | Controlled release tablets of bupropion hydrochloride |
US7667849B2 (en) * | 2003-09-30 | 2010-02-23 | British Telecommunications Public Limited Company | Optical sensor with interferometer for sensing external physical disturbance of optical communications link |
GB0322859D0 (en) * | 2003-09-30 | 2003-10-29 | British Telecomm | Communication |
UA82597C2 (en) | 2004-02-04 | 2008-04-25 | Алембик Лимитед | Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
GB0407386D0 (en) * | 2004-03-31 | 2004-05-05 | British Telecomm | Monitoring a communications link |
US7848645B2 (en) | 2004-09-30 | 2010-12-07 | British Telecommunications Public Limited Company | Identifying or locating waveguides |
GB0421747D0 (en) * | 2004-09-30 | 2004-11-03 | British Telecomm | Distributed backscattering |
EP1825613B1 (en) | 2004-12-17 | 2011-02-16 | BRITISH TELECOMMUNICATIONS public limited company | Assessing a network |
GB0427733D0 (en) * | 2004-12-17 | 2005-01-19 | British Telecomm | Optical system |
GB0504579D0 (en) * | 2005-03-04 | 2005-04-13 | British Telecomm | Communications system |
DE602006007442D1 (en) * | 2005-03-04 | 2009-08-06 | British Telecomm Public Ltd Co | AKUSTOOPTICAL MODULATOR ASSEMBLY |
EP1708388A1 (en) | 2005-03-31 | 2006-10-04 | British Telecommunications Public Limited Company | Communicating information |
WO2006109693A1 (en) * | 2005-04-08 | 2006-10-19 | Eisai R & D Management Co., Ltd. | Sampling device for viscous sample, method of homogenizing sputum and method of detecting microorganism |
EP1713301A1 (en) * | 2005-04-14 | 2006-10-18 | BRITISH TELECOMMUNICATIONS public limited company | Method and apparatus for communicating sound over an optical link |
US20080175873A1 (en) * | 2005-06-02 | 2008-07-24 | Biovail Laboratories International S.R.L. | Modified release composition of at least one form of venlafaxine |
EP1729096A1 (en) * | 2005-06-02 | 2006-12-06 | BRITISH TELECOMMUNICATIONS public limited company | Method and apparatus for determining the position of a disturbance in an optical fibre |
JP5302005B2 (en) * | 2005-12-01 | 2013-10-02 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | Substituted phenethylamine having serotonergic and / or norepinephrine activity |
CA2643344A1 (en) * | 2006-02-24 | 2007-08-30 | British Telecommunications Public Limited Company | Sensing a disturbance |
EP1826924A1 (en) * | 2006-02-24 | 2007-08-29 | BRITISH TELECOMMUNICATIONS public limited company | Sensing a disturbance |
CA2643345A1 (en) * | 2006-02-24 | 2007-08-30 | British Telecommunications Public Limited Company | Sensing a disturbance |
WO2007113527A1 (en) * | 2006-04-03 | 2007-10-11 | British Telecommunications Public Limited Company | Evaluating the position of a disturbance |
US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
SI2125698T1 (en) | 2007-03-15 | 2016-12-30 | Auspex Pharmaceuticals, Inc. | DEUTERATED d9-VENLAFAXINE |
US20110052690A1 (en) * | 2008-06-02 | 2011-03-03 | Avi Avramoff | Process for manufacture of a medicament with granulation and pan coating |
PL2590634T3 (en) | 2010-07-09 | 2016-10-31 | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin | |
EP2701668A1 (en) | 2011-04-29 | 2014-03-05 | Massachusetts Institute of Technology | Layer processing for pharmaceuticals |
US10213960B2 (en) | 2014-05-20 | 2019-02-26 | Massachusetts Institute Of Technology | Plasticity induced bonding |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0112669A2 (en) * | 1982-12-13 | 1984-07-04 | American Home Products Corporation | Phenethylamine derivatives and intermediates therefor |
US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
Family Cites Families (206)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US2738303A (en) * | 1952-07-18 | 1956-03-13 | Smith Kline French Lab | Sympathomimetic preparation |
US2996431A (en) * | 1953-12-16 | 1961-08-15 | Barry Richard Henry | Friable tablet and process for manufacturing same |
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
NL265428A (en) * | 1960-06-06 | |||
NL271831A (en) | 1960-11-29 | |||
US3139383A (en) * | 1961-06-26 | 1964-06-30 | Norton Co | Encapsulated time release pellets and method for encapsulating the same |
US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
US3546142A (en) | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
US3589123A (en) * | 1967-08-21 | 1971-06-29 | Messers Gebruder Junghans Gmbh | Signal device for electric alarm clocks |
DE1773005A1 (en) * | 1968-03-20 | 1971-04-08 | Kienzle Uhrenfabriken Gmbh | Electrodynamically driven balance oscillator |
US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
US3634584A (en) * | 1969-02-13 | 1972-01-11 | American Home Prod | Sustained action dosage form |
US3554905A (en) * | 1969-04-01 | 1971-01-12 | Dow Chemical Co | Process for treating water with a polyhalide resin using a semipermeable membrane barrier |
US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
US3625214A (en) * | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
US3865108A (en) * | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
US3962414A (en) * | 1972-04-27 | 1976-06-08 | Alza Corporation | Structured bioerodible drug delivery device |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
DE2254043C2 (en) | 1972-11-04 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | LH-releasing hormone for nasal application |
US3811444A (en) * | 1972-12-27 | 1974-05-21 | Alza Corp | Bioerodible ocular device |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4138474A (en) * | 1973-05-01 | 1979-02-06 | Wisconsin Alumni Research Foundation | Method and device for immunoassay |
DE2336218C3 (en) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Oral dosage form |
US3992518A (en) * | 1974-10-24 | 1976-11-16 | G. D. Searle & Co. | Method for making a microsealed delivery device |
GB1478759A (en) | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4135514A (en) * | 1974-12-23 | 1979-01-23 | Alza Corporation | Osmotic releasing system for administering ophthalmic drug to eye of animal |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4036228A (en) * | 1975-09-11 | 1977-07-19 | Alza Corporation | Osmotic dispenser with gas generating means |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4029757A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
US4197289A (en) * | 1975-12-15 | 1980-04-08 | Hoffmann-La Roche Inc. | Novel dosage forms |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4063064A (en) | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4066747A (en) * | 1976-04-08 | 1978-01-03 | Alza Corporation | Polymeric orthoesters housing beneficial drug for controlled release therefrom |
US4138471A (en) * | 1976-06-01 | 1979-02-06 | J. M. Huber Corporation | Process for reducing the polycyclic aromatic hydrocarbon content of carbon black |
US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
US4070347A (en) * | 1976-08-16 | 1978-01-24 | Alza Corporation | Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality |
US4137300A (en) * | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
US4138472A (en) * | 1976-11-10 | 1979-02-06 | Basf Aktiengesellschaft | Process for obtaining coarsely crystalline pure ammonium sulfate |
US4111201A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
AU520409B2 (en) * | 1977-05-25 | 1982-01-28 | Commonwealth Scientific And Industrial Research Organisation | Controlled release composition |
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4138473A (en) * | 1977-10-31 | 1979-02-06 | Gieck Joseph F | Process for recovering sulfur from sour gas |
US4277582A (en) * | 1978-03-03 | 1981-07-07 | Ciba-Geigy Corporation | Water-insoluble hydrophilic copolymers |
US4285987A (en) | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4250611A (en) * | 1979-04-19 | 1981-02-17 | Alza Corporation | Process for making drug delivery device with reservoir |
JPS55153715A (en) * | 1979-05-18 | 1980-11-29 | Nikken Kagaku Kk | Prolonged granule of theophylline |
US4248857A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
US4320759A (en) * | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
US4259315A (en) * | 1980-06-13 | 1981-03-31 | A. H. Robins Company, Inc. | Controlled release potassium dosage form |
US4423099A (en) * | 1980-07-28 | 1983-12-27 | Ciba-Geigy Corporation | Membrane modified hydrogels |
PH19942A (en) | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
DE3125178A1 (en) | 1981-06-26 | 1983-01-13 | Gödecke AG, 1000 Berlin | METHOD FOR THE TIMED CONTROL OF THE RELEASE OF ACTIVE SUBSTANCES FROM ACTIVE SUBSTANCE PREPARATIONS, IN PARTICULAR DRUG PREPARATIONS |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4439196A (en) * | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
US4642233A (en) * | 1982-03-22 | 1987-02-10 | Alza Corporation | Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills |
US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
US4659558A (en) * | 1982-03-22 | 1987-04-21 | Alza Corporation | Oral delivery system comprising a plurality of tiny pills for delivering drug in the stomach and intestine |
EP0094123A3 (en) | 1982-05-06 | 1984-07-25 | THE PROCTER & GAMBLE COMPANY | Therapeutic granules |
US4535186A (en) | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US4721613A (en) * | 1982-12-13 | 1988-01-26 | Alza Corporation | Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
FI831096L (en) | 1983-03-30 | 1984-10-01 | Merck & Co Inc | BIOLOGISKT LOESLIGT OKULAERT FAST AEMNE. |
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
NZ206600A (en) | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
US4761501A (en) | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
US4611078A (en) | 1983-10-26 | 1986-09-09 | American Home Products Corporation | Substituted phenylacetonitriles |
US4732915A (en) * | 1983-11-02 | 1988-03-22 | Alza Corporation | Process for increasing solubility of drug |
US4624945A (en) * | 1984-03-19 | 1986-11-25 | Alza Corporation | Dispensing system with means for increasing delivery of beneficial agent from the system |
US4535189A (en) * | 1984-03-21 | 1985-08-13 | Texaco Inc. | Polyol purification process |
KR850700212A (en) | 1984-03-21 | 1985-12-26 | 죠지 드모트 | Sustained Release Pharmaceutical Wexel |
US4624848A (en) * | 1984-05-10 | 1986-11-25 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
US4749576A (en) * | 1984-05-10 | 1988-06-07 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
DE3419129A1 (en) | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | NIFEDIPINE PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF |
US5182207A (en) * | 1984-09-14 | 1993-01-26 | American Cyanamid Company | Strains of streptomyces thermoarchaensis |
US4863744A (en) | 1984-09-17 | 1989-09-05 | Alza Corporation | Intestine drug delivery |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5204356A (en) * | 1985-07-24 | 1993-04-20 | Glaxo Group Limited | Treatment of anxiety |
ES8704080A1 (en) | 1985-08-23 | 1987-03-16 | Leo Ab | Method for producing a pharmaceutical tablet essentially coated with a terpolymer of poly(vinyl chloride), poly(vinyl acetate) and poly(vinyl alcohol) |
HU197201B (en) | 1985-10-01 | 1989-03-28 | Sandoz Ag | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
FR2588188B1 (en) | 1985-10-04 | 1988-01-08 | Delalande Sa | PROGRAMMED RELEASE CINEPAZIDE HYDROSOLUBLE SALT (S) TABLET AND PROCESS FOR PREPARING SAME |
US5185456A (en) * | 1986-03-12 | 1993-02-09 | American Cyanamid Company | Macrolide compounds |
US4986987A (en) * | 1986-05-09 | 1991-01-22 | Alza Corporation | Pulsed drug delivery |
US4948592A (en) | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
US4842867A (en) | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
US4798725A (en) * | 1986-06-16 | 1989-01-17 | Norwich Eaton Pharmaceuticals, Inc. | Sustained release capsule |
US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
US5202343A (en) * | 1986-11-28 | 1993-04-13 | Glaxo Group Limited | Tricyclic ketones useful as HT3 -receptor antagonists |
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
US4892778A (en) * | 1987-05-27 | 1990-01-09 | Alza Corporation | Juxtaposed laminated arrangement |
US5499979A (en) * | 1987-06-25 | 1996-03-19 | Alza Corporation | Delivery system comprising kinetic forces |
US4874388A (en) | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
GB2206046B (en) | 1987-06-25 | 1991-04-03 | Alza Corp | Multi-unit delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4915953A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering acetaminophen or phenylpropanolamine |
US5192777A (en) * | 1987-09-11 | 1993-03-09 | American Cyanamid Company | Macrolide compounds |
US4946687A (en) | 1987-10-02 | 1990-08-07 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US4950486A (en) | 1987-10-02 | 1990-08-21 | Alza Corporation | Dosage form for treating cardiovascular diseases |
CH672887A5 (en) | 1987-10-14 | 1990-01-15 | Debiopharm Sa | |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
US5194407A (en) * | 1987-12-16 | 1993-03-16 | Stemcor Corporation | Molten metal-resistant ceramic fiber-containing composition |
US4904474A (en) * | 1988-01-25 | 1990-02-27 | Alza Corporation | Delivery of drug to colon by oral disage form |
US4966769A (en) | 1988-06-02 | 1990-10-30 | Alza Corporation | Method for delivering dosage form for diltiazem |
DE3822095A1 (en) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF |
US5194464A (en) * | 1988-09-27 | 1993-03-16 | Takeda Chemical Industries, Ltd. | Enteric film and preparatoin thereof |
US5030456A (en) * | 1988-11-07 | 1991-07-09 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US5728088A (en) * | 1988-12-13 | 1998-03-17 | Alza Corporation | Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5196203A (en) * | 1989-01-06 | 1993-03-23 | F. H. Faulding & Co. Limited | Theophylline dosage form |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Dispensing devices powered by hydrogel |
US5019396A (en) * | 1989-05-12 | 1991-05-28 | Alza Corporation | Delivery dispenser for treating cardiac arrhythmias |
JPH035421A (en) * | 1989-05-31 | 1991-01-11 | A Baisuke Donald | Administering deprenyl drug so as to decrease risk of side effect |
US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
US5182299A (en) * | 1990-03-19 | 1993-01-26 | Brigham And Women's Hospital | Treatment of osmotic disturbance with organic osmolytes |
US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5017381A (en) * | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
GB9012469D0 (en) * | 1990-06-05 | 1990-07-25 | Glaxo Group Ltd | Medicaments |
US5057321A (en) * | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5464631A (en) | 1990-06-27 | 1995-11-07 | Warner-Lambert Company | Encapsulated dosage forms |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
US5196199A (en) * | 1990-12-14 | 1993-03-23 | Fuisz Technologies Ltd. | Hydrophilic form of perfluoro compounds and method of manufacture |
US5208037A (en) | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
US5204116A (en) * | 1991-05-01 | 1993-04-20 | Alza Corporation | Dosage form providing immediate therapy followed by prolonged therapy |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5178867A (en) * | 1991-08-19 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug in short-time period |
US5200194A (en) * | 1991-12-18 | 1993-04-06 | Alza Corporation | Oral osmotic device |
US5294770A (en) * | 1992-01-14 | 1994-03-15 | Alza Corporation | Laser tablet treatment system with dual access to tablet |
IT1255522B (en) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS |
US5869097A (en) * | 1992-11-02 | 1999-02-09 | Alza Corporation | Method of therapy comprising an osmotic caplet |
ES2077547T3 (en) * | 1992-11-17 | 2000-06-16 | Yoshitomi Pharmaceutical | SUSTAINED RELEASE MICROSPHERE CONTAINING AN ANTIPSYCHOTIC AND PRODUCTION PROCEDURE. |
US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
ES2149250T3 (en) | 1993-04-23 | 2000-11-01 | Novartis Ag | DEVICE FOR THE ADMINISTRATION OF MEDICINES WITH CONTROLLED RELEASE. |
US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
EP1738753B1 (en) * | 1993-06-28 | 2008-04-23 | Wyeth | New treatments using phenethylamine derivatives |
US5532003A (en) * | 1994-01-18 | 1996-07-02 | Alza Corporation | Pentoxifylline therapy |
US5434631A (en) * | 1994-07-21 | 1995-07-18 | Lieberman; Phillip L. | Collapsible large screen audiovisual display system |
US5718700A (en) * | 1994-09-20 | 1998-02-17 | Alza Corporation | Exit means in dosage form |
FR2725623A1 (en) * | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | MEDICINAL AND / OR NUTRITION MICROCAPSULES FOR PER OS ADMINISTRATION |
US5513293A (en) * | 1994-11-29 | 1996-04-30 | At&T Corp. | Optical backplane for a telecommunication distribution frame |
IL139728A (en) * | 1995-01-09 | 2003-06-24 | Penwest Pharmaceuticals Compan | Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient |
JP3113793B2 (en) * | 1995-05-02 | 2000-12-04 | 株式会社エヌ・ティ・ティ ファシリティーズ | Air conditioning system |
GB9514451D0 (en) * | 1995-07-14 | 1995-09-13 | Chiroscience Ltd | Sustained-release formulation |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
US6096339A (en) * | 1997-04-04 | 2000-08-01 | Alza Corporation | Dosage form, process of making and using same |
TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
PT957899E (en) | 1996-08-16 | 2003-07-31 | Alza Corp | Dosage form for providing a medicament in a rising dose |
DK0932388T5 (en) | 1996-09-30 | 2011-06-27 | Alza Corp | Dosage form and method of administration of drugs |
US6919373B1 (en) * | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
CN1182839C (en) | 1996-11-25 | 2005-01-05 | 阿尔萨公司 | Ascending-dose dosage form |
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
WO1999012526A1 (en) * | 1997-09-09 | 1999-03-18 | Alza Corporation | Pharmaceutical coating composition and method of use |
US6039977A (en) * | 1997-12-09 | 2000-03-21 | Alza Corporation | Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods |
AU1623099A (en) * | 1997-12-22 | 1999-07-12 | Alza Corporation | Rate controlling membranes for controlled drug delivery devices |
US6551613B1 (en) * | 1998-09-08 | 2003-04-22 | Alza Corporation | Dosage form comprising therapeutic formulation |
US6174547B1 (en) * | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation |
EP1126827A2 (en) * | 1998-11-02 | 2001-08-29 | Alza Corporation | Controlled delivery of active agents |
US20050048120A1 (en) * | 1998-11-04 | 2005-03-03 | Edgren David Emil | Dosage form comprising self-destructive membrane |
ATE234603T1 (en) * | 1998-12-31 | 2003-04-15 | Alza Corp | OSMOTIC ADMINISTRATION SYSTEM WITH SPACE-SAVING PISTONS |
US6348494B1 (en) * | 2000-11-21 | 2002-02-19 | American Home Products Corporation | Ethers of o-desmethyl venlafaxine |
NZ519632A (en) * | 1999-12-16 | 2004-03-26 | Alza Corp | Dosage forms that include a barrier layer containing a material that allows the layer to remain intact during laser formation of the orifice(s) |
WO2001045675A2 (en) * | 1999-12-21 | 2001-06-28 | Alza Corporation | Valve for osmotic devices |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
CA2683185A1 (en) * | 2000-02-04 | 2001-08-09 | Durect Corporation | Osmotically-driven fluid dispenser and coating composition |
CA2429945A1 (en) * | 2000-11-29 | 2002-06-06 | Durect Corporation | Devices and methods for controlled delivery from a drug delivery device |
TW200414900A (en) * | 2002-06-28 | 2004-08-16 | ||
US7014636B2 (en) * | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
CA2534920A1 (en) * | 2003-08-06 | 2005-02-24 | Alza Corporation | Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation |
EP1791520A2 (en) * | 2004-08-19 | 2007-06-06 | Alza Corporation | Controlled release nanoparticle active agent formulation dosage forms and methods |
WO2007019393A2 (en) * | 2005-08-04 | 2007-02-15 | Alza Corporation | Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties |
EP1933811A2 (en) * | 2005-09-30 | 2008-06-25 | Alza Corporation | Banded controlled release nanoparticle active agent formulation dosage forms and methods |
US8852638B2 (en) * | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
-
1993
- 1993-05-27 US US08/068,480 patent/US6440457B1/en not_active Expired - Lifetime
-
1994
- 1994-05-27 EP EP94919286A patent/EP0700289A1/en not_active Withdrawn
- 1994-05-27 AU AU70482/94A patent/AU677080B2/en not_active Ceased
- 1994-05-27 JP JP7501005A patent/JPH08510755A/en not_active Withdrawn
- 1994-05-27 CA CA002157186A patent/CA2157186A1/en not_active Abandoned
- 1994-05-27 WO PCT/US1994/006049 patent/WO1994027589A2/en not_active Application Discontinuation
- 1994-05-27 NZ NZ267841A patent/NZ267841A/en unknown
- 1994-05-27 ZA ZA943743A patent/ZA943743B/en unknown
-
1995
- 1995-11-21 NO NO954694A patent/NO954694L/en unknown
- 1995-11-24 FI FI955681A patent/FI955681A0/en unknown
- 1995-11-27 KR KR1019950705306A patent/KR960702303A/en not_active Application Discontinuation
-
2003
- 2003-10-28 US US10/696,217 patent/US20040092601A1/en not_active Abandoned
- 2003-10-28 US US10/696,370 patent/US20040086570A1/en not_active Abandoned
-
2005
- 2005-12-22 US US11/315,434 patent/US20060099263A1/en not_active Abandoned
-
2006
- 2006-09-15 US US11/522,014 patent/US8084059B2/en not_active Expired - Fee Related
-
2007
- 2007-11-21 JP JP2007301927A patent/JP2008069177A/en not_active Withdrawn
-
2010
- 2010-06-22 US US12/820,671 patent/US20100260810A1/en not_active Abandoned
- 2010-08-02 JP JP2010173633A patent/JP2010248259A/en not_active Withdrawn
-
2011
- 2011-11-08 JP JP2011244253A patent/JP2012031208A/en active Pending
- 2011-11-23 US US13/303,244 patent/US20120070496A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0112669A2 (en) * | 1982-12-13 | 1984-07-04 | American Home Products Corporation | Phenethylamine derivatives and intermediates therefor |
US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
Also Published As
Publication number | Publication date |
---|---|
US20060099263A1 (en) | 2006-05-11 |
ZA943743B (en) | 1995-01-24 |
FI955681A (en) | 1995-11-24 |
US6440457B1 (en) | 2002-08-27 |
JP2010248259A (en) | 2010-11-04 |
US8084059B2 (en) | 2011-12-27 |
FI955681A0 (en) | 1995-11-24 |
JP2012031208A (en) | 2012-02-16 |
JP2008069177A (en) | 2008-03-27 |
US20120070496A1 (en) | 2012-03-22 |
WO1994027589A2 (en) | 1994-12-08 |
NO954694D0 (en) | 1995-11-21 |
JPH08510755A (en) | 1996-11-12 |
US20070009600A1 (en) | 2007-01-11 |
NZ267841A (en) | 1996-11-26 |
KR960702303A (en) | 1996-04-27 |
US20040086570A1 (en) | 2004-05-06 |
AU7048294A (en) | 1994-12-20 |
AU677080B2 (en) | 1997-04-10 |
NO954694L (en) | 1995-11-24 |
EP0700289A1 (en) | 1996-03-13 |
US20040092601A1 (en) | 2004-05-13 |
US20100260810A1 (en) | 2010-10-14 |
CA2157186A1 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994027589A3 (en) | Antidepressant dosage form | |
AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
PL297747A1 (en) | Prolonged action pharmaceutical dosage forms | |
DE69738000D1 (en) | New pharmaceutical formulation containing budesonide | |
EP0745401A3 (en) | Inhaler type medicine administering device | |
IL120382A (en) | Extended release formulation of venlafaxine hydrochloride | |
GB9410987D0 (en) | High dosage pharmaceutical compositions | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
IL130784A0 (en) | Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same | |
GB2279879B (en) | Medicament inhalers | |
MX9802150A (en) | Inhibition of tumor necrosis factor alpha. | |
ZA966453B (en) | Safety minute dose hypodermic syringe. | |
AU5170499A (en) | Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis | |
ES2026304A6 (en) | Dosage form for administering calcium antagonist. | |
EP0683668A4 (en) | Compositions and methods for transdermal drug delivery. | |
EP0438147A3 (en) | Pharmaceutical compositions and dosage forms for the oral administration of calcitonin | |
IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
HUP0004410A3 (en) | A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0,5ml | |
IL109108A0 (en) | Salts of (s)-alpha- phenyl - 2 - pyridineethanamine, their preparation and pharmaceutical compositions containing them | |
GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
IL109993A0 (en) | Ipsapirone medicament formulation | |
GB9325835D0 (en) | Device for administering single doses of a medicament | |
IT1254707B (en) | TOPICAL USE OF CALCITONE FOR THE PREPARATION OF MEDICATIONS IN THE IDIOPATHIC SENILE CATARACT AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA FI JP KR NO NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA FI JP KR NO NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 267841 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2157186 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994919286 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 955681 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1994919286 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994919286 Country of ref document: EP |